Embecta Corp.

EMBC ·Healthcare, Medical Devices, United States

Net Cash Flow Breakdown

FY2025 FY2024 FY2023 FY2022 FY2021 FY2020

Total Cash from Operations: $191.7M

Line Item	Value	% of Total
Capital Expenditures	$7.6M	3.9%
Dividends Paid	$35.0M	18.3%
Other Financing	$149.1M	77.8%
Net Cash Flow	$0	0.0%